NEW YORK (GenomeWeb News) — Bioinformatics shop CLC Bio has received an undisclosed amount of new financial backing from several new private Danish investors, the company said today.
 
The new backers include Peter Bogild, Tom Nordin, and Thomas Bruno, who have a combined capital base of $200 million, the company said.
 
CLC Bio will use the funding to continue developing software for next-generation sequencing and to continue to enhance its current product line, company CEO Thomas Knudsen said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.